Literature DB >> 22800552

Prognostic factors for melanoma.

Oliver J Wisco1, Arthur J Sober.   

Abstract

The current melanoma staging system, as defined by the American Joint Committee on Cancer (AJCC), is the standard by which melanoma prognosis is determined. This article focuses on the components of the AJCC melanoma staging system regarding patient prognosis. In addition, this article summarizes the other commonly researched clinical and histologic melanoma prognostic factors and reviews the recent advancements in genetic biomarkers associated with prognosis. Published by Elsevier Inc.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22800552     DOI： 10.1016/j.det.2012.04.008

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN： 0733-8635            Impact factor:   3.478


  8 in total

1.  Prognostic survival model for people diagnosed with invasive cutaneous melanoma.

Authors:  Peter D Baade; Patrick Royston; Philipa H Youl; Martin A Weinstock; Alan Geller; Joanne F Aitken
Journal:  BMC Cancer       Date:  2015-01-31       Impact factor: 4.430

2.  Missing sentinel lymph node in cutaneous melanoma.

Authors:  Luca Dellavedova; Luigia Florimonte; Marco Carletto; Lorenzo Stefano Maffioli
Journal:  Indian J Nucl Med       Date:  2015 Apr-Jun

3.  Host kinin B1 receptor plays a protective role against melanoma progression.

Authors:  Andrea G Maria; Patrícia Dillenburg-Pilla; Rosana I Reis; Elaine M Floriano; Cristiane Tefé-Silva; Simone G Ramos; João B Pesquero; Clara Nahmias; Claudio M Costa-Neto
Journal:  Sci Rep       Date:  2016-02-22       Impact factor: 4.379

4.  Prognostic significance of LKB1 promoter methylation in cutaneous malignant melanoma.

Authors:  Weiming Zhang; Xiao Li; Guoxin Song; Dan Luo
Journal:  Oncol Lett       Date:  2017-06-20       Impact factor: 2.967

5.  The relative contribution of the decreasing trend in tumour thickness to the 2010s increase in net survival from cutaneous malignant melanoma in Italy: a population-based investigation.

Authors:  Federica Zamagni; Lauro Bucchi; Silvia Mancini; Emanuele Crocetti; Luigino Dal Maso; Stefano Ferretti; Annibale Biggeri; Simona Villani; Flavia Baldacchini; Orietta Giuliani; Alessandra Ravaioli; Rosa Vattiato; Angelita Brustolin; Giuseppa Candela; Simona Carone; Giuliano Carrozzi; Rossella Cavallo; Ylenia Maria Dinaro; Margherita Ferrante; Silvia Iacovacci; Guido Mazzoleni; Antonino Musolino; Roberto Vito Rizzello; Diego Serraino; Fabrizio Stracci; Rosario Tumino; Carla Masini; Laura Ridolfi; Giuseppe Palmieri; Ignazio Stanganelli; Fabio Falcini
Journal:  Br J Dermatol       Date:  2022-05-31       Impact factor: 11.113

6.  Long-term survival analysis and clinical follow-up in acral lentiginous malignant melanoma undergoing sentinel lymph node biopsy in korean patients.

Authors:  Su-Young Jeon; Jin-Woo Hong; Suee Lee; Sung Yong Oh; Young-Seoub Hong; Ki-Ho Kim; Ki-Hoon Song
Journal:  Ann Dermatol       Date:  2014-04-30       Impact factor: 1.444

7.  High LIFr expression stimulates melanoma cell migration and is associated with unfavorable prognosis in melanoma.

Authors:  Hongwei Guo; Yabin Cheng; Magdalena Martinka; Kevin McElwee
Journal:  Oncotarget       Date:  2015-09-22

8.  Clinicopathological predictors of recurrence in nodular and superficial spreading cutaneous melanoma: a multivariate analysis of 214 cases.

Authors:  Maria A Pizzichetta; Daniela Massi; Mario Mandalà; Paola Queirolo; Ignazio Stanganelli; Vincenzo De Giorgi; Giovanni Ghigliotti; Stefano Cavicchini; Pietro Quaglino; Maria T Corradin; Pietro Rubegni; Mauro Alaibac; Stefano Astorino; Fabrizio Ayala; Serena Magi; Laura Mazzoni; Maria Ausilia Manganoni; Renato Talamini; Diego Serraino; Giuseppe Palmieri
Journal:  J Transl Med       Date:  2017-11-07       Impact factor: 5.531
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.